Excluded
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
---
-
-估算股数样本
IN
HealthcareBiotechnologyUnited States
INSM.US · Insmed Incorporated
NMS · US · USD
Latest price135.17美元
30D-3.1%
Vs. base value-
Research summary
INSM.US latest organized financial period shows revenue year-over-year comparison is not complete and net income down 39.73% year over year. Current price is about 135.17美元, while the model base case is about -; valuation gap needs more complete inputs. This summary is intended for public-information research and model review.
Key financial trend
Unit: 美元
Revenue-
Net income-12.77亿美元
Free cash flow-9.68亿美元
Operating cash flow-9.35亿美元
Price trend
Price date: 2026/04/23 · Updated: 2026/04/25 07:54
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price135.17美元
Base value-
Vs. base-
Price date2026/04/23
---
-
Excluded
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
---
-
-估算股数样本
Excluded
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
---
-
-估算股数样本
Excluded
Earnings Power Value
Estimates earnings power value without assuming growth.
---
-
-估算股数样本
Updated: 2026/04/25 07:54
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 80
| Period | Type | Revenue | Net Income | Free Cash Flow | Diluted EPS |
|---|---|---|---|---|---|
| 2025/12/30 | Annual | - | -12.77亿美元 | -9.68亿美元 | -6.42 |
| 2024/12/30 | Annual | - | -9.14亿美元 | -7.06亿美元 | -5.57 |
| 2023/12/30 | Annual | - | -7.5亿美元 | -5.5亿美元 | -5.34 |
| 2022/12/30 | Annual | - | -4.82亿美元 | -4.1亿美元 | -3.91 |
| 2021/12/30 | Annual | - | -4.35亿美元 | -3.71亿美元 | -3.88 |
Related stocks
View allAd placement